Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19

In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and u...

Descripción completa

Detalles Bibliográficos
Autor principal: Turner, Leigh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203029/
https://www.ncbi.nlm.nih.gov/pubmed/32464095
http://dx.doi.org/10.1016/j.stem.2020.05.003
_version_ 1783529795396567040
author Turner, Leigh
author_facet Turner, Leigh
author_sort Turner, Leigh
collection PubMed
description In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.
format Online
Article
Text
id pubmed-7203029
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72030292020-05-07 Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19 Turner, Leigh Cell Stem Cell Forum In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19. Elsevier Inc. 2020-06-04 2020-05-07 /pmc/articles/PMC7203029/ /pubmed/32464095 http://dx.doi.org/10.1016/j.stem.2020.05.003 Text en © 2020 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Forum
Turner, Leigh
Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
title Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
title_full Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
title_fullStr Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
title_full_unstemmed Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
title_short Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
title_sort preying on public fears and anxieties in a pandemic: businesses selling unproven and unlicensed “stem cell treatments” for covid-19
topic Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203029/
https://www.ncbi.nlm.nih.gov/pubmed/32464095
http://dx.doi.org/10.1016/j.stem.2020.05.003
work_keys_str_mv AT turnerleigh preyingonpublicfearsandanxietiesinapandemicbusinessessellingunprovenandunlicensedstemcelltreatmentsforcovid19

Ejemplares similares